Resistant to Tyrosine Kinase Inhibitor Therapy

Also known as: Resistant to tyrosine kinase inhibitors

DrugDrug NameDrug Description
DB04868NilotinibA kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib.
DrugDrug NamePhaseStatusCount
DB04868Nilotinib1 / 2Completed1
DB08877Ruxolitinib1 / 2Completed1